Archive for the ‘Glucose Monitoring’ Category

Sensors for Medicine and Science Inc (SMSI) is developing a new approach to glucose monitoring that promises to be a long-awaited improvement over present methods, which typically require several finger prick blood tests a day. This inconvenient and uncomfortable method of collecting blood samples results in many diabetics not testing their blood sugar as often as they should.

The new glucose monitoring method involves a small sensor that is implanted under the skin. The sensor automatically monitors glucose levels every few minutes, and transmits the information wirelessly to a small wrist-watch-like external reader. The sensor will also warn the wearer of an impending episode of low or high blood sugar.

The sensor would be of obvious benefit to insulin dependent diabetics whose diabetes is not well controlled or whose blood sugar levels swing unpredictably. It would also be ideal for children with diabetes.

Sensors for Medicine and Science will be presenting the results of a successful pilot study of the glucose monitor at the next meeting of the European Association for the Study of Diabetes. “Based on the promising results obtained,” says CEO Tim Goodnow, PhD, “We plan to initiate more clinical trials in the very near future.”

The company also hopes to collaborate on artificial pancreas research, with many questions to be answered.

Abbott Diabetes Care is alerting its diabetic customers that it has been forced to discontinue its FreeStyle Navigator Continuous Glucose Monitoring System in the US. The FreeStyle Navigator System will still be available in seven other national markets.

The discontinuation results from supply interruptions that affected the company’s ability to provide American customers with new system kits or replacement components. Abbott stresses that there were no safety issues with the continuous glucose monitoring system.

Abbott plans to help its FreeStyle Navigator customers transition to the three remaining continuous glucose monitoring systems on the market. To read the discontinuation notice on the Abbott Diabetes Care website, and get information on how Abbott plans to help its customers with the transition to other monitoring systems, >Click Here.<

glucose monitor

Glucose monitor

According to a HealthDay News article, intensive glucose-lowering treatment for people with type 2 diabetes doesn’t reduce the risk of cardiovascular-related death, and doctors need to be cautious about prescribing this type of treatment.

Patients with type 2 diabetes are at increased risk for cardiovascular disease. Intensive glucose-lowering treatment is widely used for these patients even though previous research hasn’t shown any clear benefits, researchers pointed out in a report published in a recent online edition of the British Medical Journal.

Catherine Cornu, a research physician at the Clinical Investigation Centre, Louis Pradel Hospital in Bron, France, and colleagues reviewed 13 studies that included a total of 34,533 diabetes patients — 18,315 who underwent intensive glucose-lowering treatment and 16,218 who received standard treatment.

To read the full article on HealthDay News, >CLICK HERE.<

About.com diabetes guide Gary Gilles has written an informative guide to finding the best blood sugar meter. The guide covers important features and new developments in blood glucose meters, such as audible meters, meters that can communicate with an insulin pump, and glucose meters that also test blood ketones. >CLICK HERE< to read the blood sugar meter guide on About.com.

The gold standard hemoglobin HbA1c glucose monitoring test may soon lose ground to an alternative test recently developed in Tokyo. The new glycated albumin (GA) assay test measures blood sugar over 17 days, as opposed to over 3 months for HbA1c testing. This enables the GA to give a more accurate picture of diabetes control in patients with rapid changes in blood sugar levels.

HbA1c testing, which averages blood glucose levels over three months, has long been the most widespread and trusted form of blood sugar monitoring in diabetes. While it has proved a valuable tool in both diagnosing and monitoring diabetes, recent studies have questioned its effectiveness in children, and in diabetics with kidney failure. Read the full article

Photo: Marcin Mincer

The Ford Motor Company is working with Medtronic Inc, a leading manufacturer of blood glucose monitors, to expand Ford’s onboard Sync communication system to provide blood sugar monitoring for diabetic drivers. The prototype software monitors blood sugar, displays readouts on the dashboard, and warns the driver if his or her blood glucose is approaching dangerously high or low levels.

The driver can also request blood sugar updates using voice commands. The system can also be used to monitor the blood sugar levels of the vehicle’s passenger, such as a diabetic child.

The blood sugar monitoring software uses a Bluetooth connection on the driver’s phone to transmit information to the dashboard from a continuous glucose monitor worn on the body. If the driver’s blood glucose levels dip to the point where it could cause symptoms like lightheadedness, disorientation, loss of coordination and blurry vision, a robotic voice alerts the driver. Read the full article

 

Researchers in England are saying that diabetes patients not only receive no advantage, but could actually experience a disadvantage, from lowering their blood sugar below 7 or 7.5 percent hemoglobin A1c. Hemoglobin A1c is a form of hemoglobin used to identify the average plasma glucose concentration over a period of two to three months.

After reviewing the results of several studies, the researchers are advising type 2 diabetics and their healthcare providers to avoid overly aggressive treatment requiring a lot of intervention or diabetes medication. To view a WebMD video on the possible health risks of lowering your blood sugar too much on >CLICK HERE<.

Canadian pharmacies are now selling a blood glucose meter that promises to change the experience of blood sugar testing for diabetics. The Accu Chek Mobile has been available overseas since last year, but is only now available in Canada. This all-in-one meter boasts a unique testing system that will simplify the time consuming and sometimes frustrating process of checking blood sugar levels.

No Individual Strips
Unlike conventional blood glucose meters, the Accu Chek Mobile does not use an individual test strip. Instead there is a ribbon of testing material, placed in the machine like a cassette. The cassette winds itself and the display tells you how many tests remain. This method means fewer wasted strips and faster testing times, and is more convenient for people with poor eyesight or shaky hands. Each roll allows 50 tests and is easy to replace.
Read the full article